Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
AVMBioMed logo — company profile

AVMBioMed

Founded 2013 United States Limerick, United States 2 employees

General Information

Company Name AVMBioMed
Founded Year 2013
Location United States Limerick, United States +1
Employees 2
Social

Get notified when AVMBioMed moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AVMBioMed

AVMBioMed is a contract research organization (CRO) founded in 2013 and based in the United States. The company specializes in the novel discovery of post-translational modifications (PTM) and has developed Snapshot Proteomics™ technology, which utilizes protein microarrays to capture PTMs from complex mixtures like cell extracts and patient samples. This technology also identifies specific protein-protein interactions and reveals novel enzyme-substrate pairings. AVMBioMed's services offer powerful and novel information for basic science, target validation, preclinical compound characterization, and biomarker discovery. The company's focus on cutting-edge technology and its potential to impact various industries make it an intriguing prospect for investors looking to support innovative ventures in the life sciences and technology sectors. For more information, you can visit their website at www.avmbiomed.com.

No funding data available for AVMBioMed yet.

Get notified when AVMBioMed raises funding

AVMBioMed Alternatives & Competitors

AVMBioMed vs
Differentiated Therapeutics Inc
Differentiated Therapeutics Inc United States

What if you could predict molecules to make the cause of disease disappear?

Seed
3 employees
Biotechnology, Health and Wellness
AVMBioMed vs
Protillion Biosciences
Protillion Biosciences United States

Revolutionary deep tech for the design and development of protein-based drugs

Series A
23 employees
Biopharma, Biotechnology
AVMBioMed vs
PTM BIO LLC
PTM BIO LLC United States

The mission of PTM BIO is to address the unmet needs for life sciences and personalized medicine, by...

30 employees
Biotechnology, Health Care

FAQ About AVMBioMed

AVMBioMed is a contract research organization (CRO) specializing in the novel discovery of post-translational modifications (PTM). Our Snapshot Proteomics™ technology uses protein microarrays to capture PTM from complex mixtures like cell extracts and patient samples, identifies specific protein-pro...
AVMBioMed was founded in 2013.
AVMBioMed is headquartered in Limerick, United States.
AVMBioMed has approximately 2 employees.
Top alternatives and competitors to AVMBioMed include Differentiated Therapeutics Inc, Protillion Biosciences, PTM BIO LLC, Nuclera, UVic Genome BC Proteomics Centre. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AVMBioMed and Differentiated Therapeutics Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AVMBioMed and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy